4//SEC Filing
Naos Yaron 4
Accession 0001104659-20-094751
CIK 0001006281other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 5:01 PM ET
Size
11.2 KB
Accession
0001104659-20-094751
Insider Transaction Report
Form 4
Naos Yaron
Sr. VP, Operations
Transactions
- Award
Stock Options (Right to Buy)
2020-08-11+122,656→ 122,656 totalExercise: $3.59Exp: 2030-08-11→ Common Stock (122,656 underlying)
Footnotes (2)
- [F1]The shares of common stock underlying the stock options shall vest in 16 equal quarterly installments commencing upon the date of grant. The stock options are subject to accelerated vesting upon a corporate transaction or a change in control as described in the Protalix BioTherapeutics, Inc., Amended and Restated 2006 Stock Incentive Plan, as amended.
- [F2]Does not include (i) options to purchase 5,000 shares of common stock at an exercise price equal to $17.20 per share that expire on March 23, 2025 and (ii) options to purchase 60,000 shares of common stock at an exercise price equal to $5.60 per share that expire on September 13, 2028.
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001742727
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 5:01 PM ET
- Size
- 11.2 KB